Cite
HARVARD Citation
Soini, E. et al. (2017). Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert review of pharmacoeconomics & outcomes research. pp. 293-302. [Online].